Lantern Pharma Inc. – NASDAQ:LTRN
Lantern Pharma stock price today
$4.25
+0.83
+24.27%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Lantern Pharma stock price monthly change
-22.62%
month
Lantern Pharma stock price quarterly change
-22.62%
quarter
Lantern Pharma stock price yearly change
-14.29%
year
Lantern Pharma key metrics
Market Cap | 32.46M |
Enterprise value | 17.64M |
P/E | -3.71 |
EV/Sales | N/A |
EV/EBITDA | -1.25 |
Price/Sales | N/A |
Price/Book | 0.97 |
PEG ratio | 0.23 |
EPS | -1.63 |
Revenue | N/A |
EBITDA | -19.26M |
Income | -17.53M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLantern Pharma stock price history
Lantern Pharma stock forecast
Lantern Pharma financial statements
| Jun 2023 | 0 | -4.74M | |
|---|---|---|---|
| Sep 2023 | 0 | -3.16M | |
| Dec 2023 | 261.05K | -4.18M | -1603.48% |
| Mar 2024 | 0 | -5.44M |
| 2025 | 0 | -27.65M | |
|---|---|---|---|
| 2026 | 1.95M | -18.58M | -953.23% |
| 2027 | 14.6M | -13.87M | -95.06% |
| 2028 | 33.8M | -9.10M | -26.95% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 51426024 | 3.16M | 6.16% |
|---|---|---|---|
| Sep 2023 | 47771508 | 2.35M | 4.94% |
| Dec 2023 | 43647616 | 2.73M | 6.28% |
| Mar 2024 | 39734224 | 3.96M | 9.99% |
| Jun 2023 | -3.59M | -457.24K | -690.79K |
|---|---|---|---|
| Sep 2023 | -3.61M | 231.72K | 0 |
| Dec 2023 | -3.38M | 256.18K | -499.99K |
| Mar 2024 | -3.06M | -556.16K | 54.71K |
Lantern Pharma alternative data
| Aug 2023 | 22 |
|---|---|
| Sep 2023 | 22 |
| Oct 2023 | 22 |
| Nov 2023 | 22 |
| Dec 2023 | 22 |
| Jan 2024 | 22 |
| Feb 2024 | 22 |
| Mar 2024 | 21 |
| Apr 2024 | 21 |
| May 2024 | 21 |
| Jun 2024 | 21 |
| Jul 2024 | 21 |
Lantern Pharma other data
5.57%
-4.21%
of LTRN is owned by hedge funds
607.09K
-459.33K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2023 | 0 | 290696 |
| Jan 2024 | 0 | 117778 |
| Feb 2024 | 0 | 288000 |
| May 2024 | 0 | 60000 |
| Patent |
|---|
Application Filling date: 8 Sep 2021 Issue date: 2 Jun 2022 |
Application Filling date: 14 Apr 2021 Issue date: 29 Jul 2021 |
Application Filling date: 4 Mar 2021 Issue date: 1 Jul 2021 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 18 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Lantern Pharma stock today?
One share of Lantern Pharma stock can currently be purchased for approximately $4.25.
-
When is Lantern Pharma's next earnings date?
Unfortunately, Lantern Pharma's (LTRN) next earnings date is currently unknown.
-
Does Lantern Pharma pay dividends?
No, Lantern Pharma does not pay dividends.
-
How much money does Lantern Pharma make?
Lantern Pharma has a market capitalization of 32.46M.
-
What is Lantern Pharma's stock symbol?
Lantern Pharma Inc. is traded on the NASDAQ under the ticker symbol "LTRN".
-
What is Lantern Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Lantern Pharma?
Shares of Lantern Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Lantern Pharma's key executives?
Lantern Pharma's management team includes the following people:
- Mr. Panna Sharma Pres, Chief Executive Officer & Director(age: 54, pay: $750,490)
- Mr. David R. Margrave Chief Financial Officer & Sec.(age: 64, pay: $298,880)
- Dr. Kishor Gopaldas Bhatia Ph.D. Chief Scientific Officer & Scientific Consultant(age: 70, pay: $92,890)
-
How many employees does Lantern Pharma have?
As Jul 2024, Lantern Pharma employs 21 workers.
-
When Lantern Pharma went public?
Lantern Pharma Inc. is publicly traded company for more then 5 years since IPO on 11 Jun 2020.
-
What is Lantern Pharma's official website?
The official website for Lantern Pharma is lanternpharma.com.
-
Where are Lantern Pharma's headquarters?
Lantern Pharma is headquartered at 1920 McKinney Avenue, Dallas, TX.
-
How can i contact Lantern Pharma?
Lantern Pharma's mailing address is 1920 McKinney Avenue, Dallas, TX and company can be reached via phone at +972 2771136.
Lantern Pharma company profile:
Lantern Pharma Inc.
lanternpharma.comExchange:
NASDAQ
Full time employees:
21
Industry:
Biotechnology
Sector:
Healthcare
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
1920 McKinney Avenue
Dallas, TX 75201
Dallas, TX 75201
CIK: 0001763950
ISIN: US51654W1018
CUSIP: 51654W101
